ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Oral P2Y12 inhibitors in acute coronary syndromes: are they all equal?
Event:
ESC Congress 2018
Topic:
Pharmacotherapy
Session type:
Rapid Fire Abstracts
Date:
28 August 2018
Time:
16:45 - 17:45
Congress Session
0
6
presentations
in this session
Type of P2Y12 inhibitor at the acute stage and one-year mortality in acute myocardial infarction. The FAST-MI programme
Speaker:
Professor N. Danchin (Paris, FR)
Access
Abstract
Slides
Video
0
A head-to-head comparison of uniform prasugrel treatment vs. clopidogrel treatment for confirmed responders in acute coronary syndrome patients: results from the randomized TROPICAL-ACS trial
Speaker:
Doctor R. Hein (Munich, DE)
Access
Abstract
Slides
Video
0
Prasugrel vs Ticagrelor in patients with acute coronary syndrome and diabetes: a propensity match substudy of RENAMI
Speaker:
Doctor M. Bertaina (Turin, IT)
Access
Abstract
Slides
Video
0
Next generation P2Y12 inhibitors improve survival in ACS: An analysis from the British Cardiovascular Intervention Society database.
Speaker:
Doctor H. Contractor (Manchester, GB)
Access
Abstract
Slides
Video
0
Prognostic impact of the new P2Y12 (ticagrelor and prasugrel) versus clopidogrel in acute coronary syndrome patients in relation to renal function
Speaker:
Mrs M. Castineira Busto (Vigo, ES)
Access
Abstract
Slides
Video
0
The OPTIDUAL trial: long term follow-up
Speaker:
Professor G. Helft (Paris, FR)
Access
Abstract
Video
0
6
speakers
from this session
Professor Nicolas Danchin
AP-HP - European Hospital Georges Pompidou, Paris (France)
13
presentations
0
follower
Doctor Ralph Hein
Klinikum Neuperlach, Munich (Germany)
0
follower
Doctor Maurizio Bertaina
San Giovanni Battista – Molinette Hospital, Turin (Italy)
0
follower
Doctor Hussain Contractor
Manchester University Hospitals, Manchester (United Kingdom of Great Britain & Northern Ireland)
0
follower
Mrs Maria Castineira Busto
University Hospital Alvaro Cunqueiro, Vigo (Spain)
0
follower
Professor Gerard Helft
Institut de Cardiologie, Paris (France)
0
follower
This platform is supported by